Source: Eur Respir J 2004; 23: 947-953
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Peacock A., Naeije R., Galie N., Reeves J.T.. End points in pulmonary arterial hypertension: the way forward. Eur Respir J 2004; 23: 947-953

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension Source: Eur Respir Rev 2013; 22: 20-25 Year: 2013 Central vascular pressure measurements during exercise in COPD: How to handle the respirophasic changes? Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013 Pulmonary arterial hypertension: genetics, reversibility testing and follow-up Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=33 Year: 2004 Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm Source: Eur Respir J 2015; 46: 299-302 Year: 2015 Cardiac function during exercise in pulmonary arterial hypertension Source: Annual Congress 2005 - Exercise in pulmonary hypertension Year: 2005 The study of risk in pulmonary arterial hypertension Source: Eur Respir Rev 2012 21:234-238 Year: 2012 The prevalence of ventilatory limitation at peak exercise in pulmonary arterial hypertension Source: International Congress 2014 – Alterations of exercise and lung function in different diseases Year: 2014 Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension Source: Eur Respir J 2011; 38: 608-616 Year: 2011 Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review Source: Eur Respir J 2009; 34: 888-894 Year: 2009 The pathobiology and genetics of pulmonary hypertension Source: Annual Congress 2006 - Pulmonary hypertension at the crossroads of science and clinical medicine Year: 2006 Pathophysiology of exercise limitation in patients with pulmonary arterial hypertension Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension Year: 2005 Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease Source: Eur Respir Rev 2011; 20: 236-242 Year: 2011 Measurement of quality of life in pulmonary hypertension and its significance Source: Eur Respir J 2006 Oct 01;28(4):808-815 Year: 2006 Dipyridamole as adjuvant therapy in patients with pulmonary arterial hypertension. A pilot study Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment Year: 2007 Relationship of quality of life and life expectancy with tolerance to physical exercises and cardio respiratory parameters in patients with pulmonary arterial hypertension Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 About cardiac output assessment in pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Pregnancy outcomes in pulmonary arterial hypertension in the modern management era}, Source: Eur Respir J 2012; 40: 881-885 Year: 2012 Survival in pulmonary hypertension in Spain: insights from the Spanish registry}, Source: Eur Respir J 2012; 40: 596-603 Year: 2012